NCT02159976View on ClinicalTrials.gov

Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea

NACompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

April 30, 2016

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Pantoprazole

Pantoprazole 40mg bid

DRUG

Amoxicillin

Amoxicillin 1000mg bid

DRUG

Clarithromycin

Clarithromycin 500mg bid

DRUG

Metronidazole

Metronidazole 500mg tid

DRUG

Tetracycline

Tetracycline 1000mg bid

DRUG

Bismuth

Bismuth 600mg bid

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

Sponsors
All Listed Sponsors
collaborator

SK Chemicals Co., Ltd.

INDUSTRY

collaborator

Chong Kun Dang Pharmaceutical

INDUSTRY

collaborator

HK inno.N Corporation

INDUSTRY

collaborator

Green Cross Corporation

INDUSTRY

lead

Seoul National University Bundang Hospital

OTHER